about
Crystallographic studies of chemically modified nucleic acids: a backward glanceTriplex-induced recombination and repair in the pyrimidine motif.Solution structure of a DNA duplex with a chiral alkyl phosphonate moietyCrystal structures of B-DNA with incorporated 2'-deoxy-2'-fluoro-arabino-furanosyl thymines: implications of conformational preorganization for duplex stabilityRegulating eukaryotic gene expression with aptamers.An improved synthesis of oligodeoxynucleotide N3'-->P5' phosphoramidates and their chimera using hindered phosphoramidite monomers and a novel handle for reverse phase purification.FTIR and UV spectroscopy studies of triplex formation between alpha-oligonucleotides with non-ionic phoshoramidate linkages and DNA targets.Re-examination of the intrinsic, dynamic and hydration properties of phosphoramidate DNA.Hydration effects on the duplex stability of phosphoramidate DNA-RNA oligomers.The ups and downs of nucleic acid duplex stability: structure-stability studies on chemically-modified DNA:RNA duplexesAntileukemia effect of c-myc N3'-->P5' phosphoramidate antisense oligonucleotides in vivo.Oligonucleotides and polyribonucleotides: a review of antiviral activity.Modulation of gene expression by antisense and antigene oligodeoxynucleotides and small interfering RNA.Purine twisted-intercalating nucleic acids: a new class of anti-gene molecules resistant to potassium-induced aggregation.Stable triple helices formed by oligonucleotide N3'-->P5' phosphoramidates inhibit transcription elongation.Bioconjugation of oligonucleotides for treating liver fibrosis.Fast and accurate nonenzymatic copying of an RNA-like synthetic genetic polymerNanotechnologies and controlled release systems for the delivery of antisense oligonucleotides and small interfering RNA.Antisense drug discovery and development.RNA and N3'-->P5' kissing aptamers targeted to the trans-activation responsive (TAR) RNA of the human immunodeficiency virus-1.High-affinity triplex targeting of double stranded DNA using chemically modified peptide nucleic acid oligomers.Triplex formation with 2'-O,4'-C-ethylene-bridged nucleic acids (ENA) having C3'-endo conformation at physiological pH.Molecular recognition properties of IGS-mediated reactions catalyzed by a Pneumocystis carinii group I intron.Antisense Oligonucleotide-Based Therapy for Neuromuscular Disease.Oligonucleotide N3'-->P5' phosphoramidates as antisense agents.Base-boronated dinucleotides: synthesis and effect of N7-cyanoborane substitution on the base protons.Stabilization of triple-stranded oligonucleotide complexes: use of probes containing alternating phosphodiester and stereo-uniform cationic phosphoramidate linkages.Oligo-2'-fluoro-2'-deoxynucleotide N3'-->P5' phosphoramidates: synthesis and properties.RNase H-independent antisense activity of oligonucleotide N3 '--> P5 ' phosphoramidates.Zwitterionic oligodeoxyribonucleotide N3'-->P5' phosphoramidates: synthesis and properties.alpha-Oligodeoxyribonucleotide N3'-->P5' phosphoramidates: synthesis and duplex formationSynthesis and physical and physiological properties of 4'-thioRNA: application to post-modification of RNA aptamer toward NF-kappaBAltered structural fluctuations in duplex RNA versus DNA: a conformational switch involving base pair opening.A new modified DNA enzyme that targets influenza virus A mRNA inhibits viral infection in cultured cells.Linker phosphoramidite reagents for the attachment of the first nucleoside to underivatized solid-phase supports.Antisense Oligodeoxynucleotide Technology: Potential Use for the Treatment of Malignant Brain Tumors.Toward a designed genetic system with biochemical function: polymerase synthesis of single and multiple size-expanded DNA base pairsNew approaches for cancer treatment: antitumor drugs based on gene-targeted nucleic acids.Synthesis and purification of oligonucleotide N3'-->P5' phosphoramidates and their phosphodiester and phosphorothioate chimeras.Synthesis and properties of 4'-ThioDNA: unexpected RNA-like behavior of 4'-ThioDNA.
P2860
Q24608092-490650BD-AD14-47A5-ADC3-FDBA08186107Q24810418-0B7FA996-AD52-42A5-B7FC-C76FDA6F62CDQ27633175-5965E5EB-48A7-44DD-B992-4906543C7DEBQ27757232-1F673F83-F733-4C07-833D-4BE8A63073F1Q31067509-A6923938-4990-4699-9AE1-2931263A55D9Q32048205-8A9CC288-2A64-4D59-A538-2F41255134D8Q33194999-EBABF9A4-B34A-4B00-B303-946300CC0985Q33940985-26D531C3-F2A9-4C11-9676-A72D321F9793Q34625840-E1B6D8F5-9ADC-4A71-B7F6-C75EE89509CFQ34645854-D17CB818-0EC8-457B-A255-D5ED0C854E86Q36108131-42929D3C-6D51-4540-BA1F-03FA54D32B13Q36124734-3DF37529-BF39-4C34-8118-F6C28EB10ACAQ36316652-22F1FC8A-75AE-4F75-B491-4689DE2F9175Q36715514-2FE8B2D0-8298-4F5C-B871-3B0816F6D41DQ36799292-89CDE173-BF11-4D50-A403-5907AFDDA721Q37043515-D4DA2137-E7C3-4CBD-830D-5F41F955F1B5Q37276593-927FC1BE-2015-40D6-AF2A-525F649CCCC7Q37444136-84CDBCB4-2819-4970-83FB-A93E57E6689AQ37859009-A3FD3176-0AD8-426F-B6C2-AE47A322A7B0Q38296793-FC469D80-6F60-40D7-8BF9-11868A9C9ADCQ38353725-C11B8250-20C7-4016-AC0E-6DA66A2AF8E9Q38353733-C6679195-E82F-41AD-A9D8-DB5FC50C7C1BQ38356388-5FD05ECF-267C-4C16-A1D0-23BD0A8B6CE2Q38734734-76F065DE-5599-4DC7-8B1B-76BED155E52BQ39716115-F0E7D097-C46C-4010-A351-E2BED9761028Q39716435-7A60133A-4761-4E8F-A699-BDF4C402C77CQ39716577-9853C9B5-32ED-4CEF-B7C2-38B9BE3868F7Q39717118-543A4A88-C2C4-43E0-BFD1-BA7F3A2B782CQ39719200-E2CD9C69-18BD-46CE-B55B-17B13B396C7BQ39722547-F37C9684-E0B8-464B-B41F-6515CCA8CEFDQ39722977-2BAD8AF6-0F5E-4D4D-9FF4-78B0DE00D7AAQ39752190-6AF45989-0787-4C3D-A4E9-60883C07D011Q40324047-01B95C44-D82B-4AF2-9A4F-DD55E7104BC4Q40585082-8F23DB4F-D4A4-4990-9A01-18E701886506Q40695498-47610D55-2DC3-4CBC-A6EE-05AB291C3FA1Q40770171-335AAEEF-396C-4450-AE9F-982DEA0E7071Q40989492-F9B11D9D-0E03-459D-8A6D-97962DEC25B9Q42153007-5A379BB6-CA73-4EC1-AC58-8DD87F042351Q42168618-76573C8C-3F33-4102-9D91-C697DB06CA78Q42415684-FA8311B0-7827-416B-A251-62991F83E1C0
P2860
description
1995 nî lūn-bûn
@nan
1995 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Oligonucleotide N3'-->P5' phosphoramidates
@ast
Oligonucleotide N3'-->P5' phosphoramidates
@en
Oligonucleotide N3'-->P5' phosphoramidates
@nl
type
label
Oligonucleotide N3'-->P5' phosphoramidates
@ast
Oligonucleotide N3'-->P5' phosphoramidates
@en
Oligonucleotide N3'-->P5' phosphoramidates
@nl
prefLabel
Oligonucleotide N3'-->P5' phosphoramidates
@ast
Oligonucleotide N3'-->P5' phosphoramidates
@en
Oligonucleotide N3'-->P5' phosphoramidates
@nl
P2093
P2860
P356
P1476
Oligonucleotide N3'-->P5' phosphoramidates
@en
P2093
DeDionisio LA
Gryaznov SM
Ratmeyer L
Schultz RG
P2860
P304
P356
10.1073/PNAS.92.13.5798
P407
P577
1995-06-01T00:00:00Z